The olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides

Journal of Nutritional Biochemistry

Volumn 59, Issue , 2018, Pages 17-28

  Malliou, Foteini ^a   Andreadou, Ioanna ^b   Gonzalez, Frank J ^c   Lazou, Antigone ^d   Xepapadaki, Eva ^e   Vallianou, Ioanna ^d   Lambrinidis, George ^b   Mikros, Emmanuel ^b   Marselos, Marios ^a   Skaltsounis, Alexios Leandros ^b   Konstandi, Maria ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NATIONAL CANCER INSTITUTE   (United States)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cholesterole; Mice; Oleuropein; PPAR ; Triglycerides

Indexed keywords

CHOLESTEROL; HORMONE SENSITIVE LIPASE; OLEUROPEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; TRIACYLGLYCEROL; IRIDOID; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; LUCIFERASE; PCSK9 PROTEIN, MOUSE; PROPROTEIN CONVERTASE 9;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOLIPIDEMIC ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; LIPID LIVER LEVEL; LIVER; LUCIFERASE ASSAY; MALE; MOLECULAR DOCKING; MOUSE; NONHUMAN; OLIVE TREE; PLANT LEAF; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WESTERN BLOTTING; WHITE ADIPOSE TISSUE; WILD TYPE MOUSE; ANIMAL; BLOOD; CELL CULTURE; CHEMISTRY; DRUG EFFECT; GENETICS; INBRED MOUSE STRAIN; LIVER CELL; METABOLISM; MUTANT MOUSE STRAIN;

ADIPOSE TISSUE, WHITE; ANIMALS; CELLS, CULTURED; HEPATOCYTES; HOMEOSTASIS; IRIDOIDS; LIPIDS; LUCIFERASES; MALE; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; MOLECULAR DOCKING SIMULATION; OLEA; PPAR ALPHA; PROPROTEIN CONVERTASE 9; RECEPTORS, LDL; TRIGLYCERIDES;

EID: 85049001307     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2018.05.013     Document Type: Article

References (74)

1. Subramaniam, S., Fahy, E., Gupta, S., Sud, M., Byrnes, R.W., Cotter, D., et al. Bioinformatics and systems biology of the lipidome. Chem Rev 111 (2011), 6452–6490.
2. Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115 (2007), 450–458.
3. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005), 2735–2752.
4. Lorenzo, C., Williams, K., Hunt, K.J., Haffner, S.M., The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30 (2007), 8–13.
5. Watts, G.F., Dimmitt, S.B., Fibrates, dyslipoproteinaemia and cardiovascular disease. Curr Opin Lipidol 10 (1999), 561–574.
6. Balint, B.L., Nagy, L., Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases. Endocr Metab Immune Disord Drug Targets 6 (2006), 33–43.
7. Tenenbaum, A., Fisman, E.Z., Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction. Cardiovasc Diabetol, 11, 2012, 125, 10.1186/1475-2840-11-125.
8. Barter, P.J., Rye, K.A., Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?. Arterioscler Thromb Vasc Biol 28 (2008), 39–46.
9. Michalik, L., Auwerx, J., Berger, J.P., Chatterjee, V.K., Glass, C.K., Gonzalez, F.J., et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 58 (2006), 726–741.
10. Rampler, H., Weinhofer, I., Netik, A., Forss-Petter, S., Brown, P.J., Oplinger, J.A., et al. Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy. Mol Genet Metab 80 (2003), 398–407.
11. Qu, S., Su, D., Altomonte, J., Kamagate, A., He, J., Perdomo, G., et al. PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am J Physiol Endocrinol Metab 292 (2007), E421–E434.
12. Oka, S., Zhai, P., Yamamoto, T., Ikeda, Y., Byun, J., Hsu, C.P., et al. Peroxisome proliferator activated receptor-alpha association with silent information regulator 1 suppresses cardiac fatty acid metabolism in the failing heart. Circ Heart Fail 8 (2015), 1123–1132.
13. Lemberger, T., Saladin, R., Vazquez, M., Assimacopoulos, F., Staels, B., Desvergne, B., et al. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem 271 (1996), 1764–1769.
14. Mandard, S., Muller, M., Kersten, S., Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61 (2004), 393–416.
15. Fruchart, J.C., Duriez, P., Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs Today (Barc) 42 (2006), 39–64.
16. Hansen, M.K., Connolly, T.M., Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis. Curr Opin Investig Drugs 9 (2008), 247–255.
17. Robillard, R., Fontaine, C., Chinetti, G., Fruchart, J.C., Staels, B., Fibrates. Handb Exp Pharmacol, 2005, 389–406.
18. Impellizzeri, D., Esposito, E., Mazzon, E., Paterniti, I., Di Paola, R., Bramanti, P., et al. The effects of a polyphenol present in olive oil, oleuropein aglycone, in an experimental model of spinal cord injury in mice. Biochem Pharmacol 83 (2012), 1413–1426.
19. Briante, R., La Cara, F., Tonziello, M.P., Febbraio, F., Nucci, R., Antioxidant activity of the main bioactive derivatives from oleuropein hydrolysis by hyperthermophilic beta-glycosidase. J Agric Food Chem 49 (2001), 3198–3203.
20. Oi-Kano, Y., Kawada, T., Watanabe, T., Koyama, F., Watanabe, K., Senbongi, R., et al. Oleuropein, a phenolic compound in extra virgin olive oil, increases uncoupling protein 1 content in brown adipose tissue and enhances noradrenaline and adrenaline secretions in rats. J Nutr Sci Vitaminol (Tokyo) 54 (2008), 363–370.
21. Andreadou, I., Iliodromitis, E.K., Mikros, E., Constantinou, M., Agalias, A., Magiatis, P., et al. The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr 136 (2006), 2213–2219.
22. Schrödinger Suite, Proteins Preparation Wizard-2. 2015.
23. Epik version 2.4, 2015, Schrödinger, LLC, New York, NY.
24. Impact version 5.9, 2015, Schrödinger, LLC, New York, NY.
25. Prime version 3.2, 2015, Schrödinger, LLC, New York, NY.
26. Maestro, S., Adzhigirey et al. version 10.2. 2013, Schrödinger, LLC, New York, NY.
27. Sastry, G.M., Adzhigirey, M., Day, T., Annabhimoju, R., Sherman, W., Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27 (2013), 221–234.
28. LigPrep. version 3.4, 2015, Schrödinger, LLC, New York, NY.
29. Krypotou, E., Lambrinidis, G., Evangelidis, T., Mikros, E., Diallinas, G., Modelling, substrate docking and mutational analysis identify residues essential for function and specificity of the major fungal purine transporter AzgA. Mol Microbiol 93 (2014), 129–145.
30. Akiyama, T.E., Nicol, C.J., Fievet, C., Staels, B., Ward, J.M., Auwerx, J., et al. Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J Biol Chem 276 (2001), 39088–39093.
31. Lee, S.S., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15 (1995), 3012–3022.
32. Andreadou, I., Mikros, E., Ioannidis, K., Sigala, F., Naka, K., Kostidis, S., et al. Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. J Mol Cell Cardiol 69 (2014), 4–16.
33. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L., Green, S., The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11 (1992), 433–439.
34. Lavrentiadou, S.N., Hadzopoulou-Cladaras, M., Kardassis, D., Zannis, V.I., Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors. Biochemistry 38 (1999), 964–975.
35. Edgecombe, S.C., Stretch, G.L., Hayball, P.J., Oleuropein, an antioxidant polyphenol from olive oil, is poorly absorbed from isolated perfused rat intestine. J Nutr 130 (2000), 2996–3002.
36. Pappenheimer, J.R., Reiss, K.Z., Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat. J Membr Biol 100 (1987), 123–136.
37. Del Boccio, P., Di Deo, A., De Curtis, A., Celli, N., Iacoviello, L., Rotilio, D., Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. Journal of chromatography B, analytical technologies in the biomedical and. Life Sci 785 (2003), 47–56.
38. Karavia, E.A., Papachristou, D.J., Kotsikogianni, I., Giopanou, I., Kypreos, K.E., Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice. FEBS J 278 (2011), 3119–3129.
39. Seglen, P.O., Preparation of isolated rat liver cells. Methods Cell Biol 13 (1976), 29–83.
40. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., et al. The Protein Data Bank. Nucleic Acids Res 28 (2000), 235–242.
41. Artis, D.R., Lin, J.J., Zhang, C., Wang, W., Mehra, U., Perreault, M., et al. Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci U S A 106 (2009), 262–267.
42. Vallianatou, T., Lambrinidis, G., Giaginis, C., Mikros, E., Tsantili-Kakoulidou, A., Analysis of PPAR-alpha/gamma activity by combining 2-D QSAR and molecular simulation. Mol Inform 32 (2013), 431–445.
43. DiRenzo, J., Soderstrom, M., Kurokawa, R., Ogliastro, M.H., Ricote, M., Ingrey, S., et al. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol Cell Biol 17 (1997), 2166–2176.
44. Trichopoulou, A., Costacou, T., Bamia, C., Trichopoulos, D., Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348 (2003), 2599–2608.
45. Perez-Martinez, P., Garcia-Rios, A., Delgado-Lista, J., Perez-Jimenez, F., Lopez-Miranda, J., Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr Pharm Des 17 (2011), 769–777.
46. Jemai, H., Fki, I., Bouaziz, M., Bouallagui, Z., El Feki, A., Isoda, H., et al. Lipid-lowering and antioxidant effects of hydroxytyrosol and its triacetylated derivative recovered from olive tree leaves in cholesterol-fed rats. J Agric Food Chem 56 (2008), 2630–2636.
47. Poudyal, H., Campbell, F., Brown, L., Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr 140 (2010), 946–953.
48. Eidi, A., Eidi, M., Darzi, R., Antidiabetic effect of Olea europaea L. in normal and diabetic rats. Phytother Res 23 (2009), 347–350.
49. Park, S., Choi, Y., Um, S.J., Yoon, S.K., Park, T., Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. J Hepatol 54 (2011), 984–993.
50. Hur, W., Kim, S.W., Lee, Y.K., Choi, J.E., Hong, S.W., Song, M.J., et al. Oleuropein reduces free fatty acid-induced lipogenesis via lowered extracellular signal-regulated kinase activation in hepatocytes. Nutr Res 32 (2012), 778–786.
51. Priore, P., Siculella, L., Gnoni, G.V., Extra virgin olive oil phenols down-regulate lipid synthesis in primary-cultured rat-hepatocytes. J Nutr Biochem 25 (2014), 683–691.
52. Obied, H.K., Prenzler, P.D., Ryan, D., Servili, M., Taticchi, A., Esposto, S., et al. Biosynthesis and biotransformations of phenol-conjugated oleosidic secoiridoids from Olea europaea L. Nat Prod Rep 25 (2008), 1167–1179.
53. Pineda Torra, I., Jamshidi, Y., Flavell, D.M., Fruchart, J.C., Staels, B., Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Mol Endocrinol 16 (2002), 1013–1028.
54. Fang, L., Zhang, M., Li, Y., Liu, Y., Cui, Q., Wang, N., PPARgene: a database of experimentally verified and computationally predicted PPAR target genes. PPAR Res, 2016, 2016, 6042162.
55. Rakhshandehroo, M., Hooiveld, G., Muller, M., Kersten, S., Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One, 4, 2009, e6796.
56. Cases, S., Smith, S.J., Zheng, Y.W., Myers, H.M., Lear, S.R., Sande, E., et al. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A 95 (1998), 13018–13023.
57. Zimmermann, R., Strauss, J.G., Haemmerle, G., Schoiswohl, G., Birner-Gruenberger, R., Riederer, M., et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306 (2004), 1383–1386.
58. Nourbakhsh, M., Douglas, D.N., Pu, C.H., Lewis, J.T., Kawahara, T., Lisboa, L.F., et al. Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production. J Hepatol 59 (2013), 336–343.
59. Brozovic, S., Nagaishi, T., Yoshida, M., Betz, S., Salas, A., Chen, D., et al. CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med 10 (2004), 535–539.
60. Brasaemle, D.L., Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 48 (2007), 2547–2559.
61. Ducharme, N.A., Bickel, P.E., Lipid droplets in lipogenesis and lipolysis. Endocrinology 149 (2008), 942–949.
62. Mori, M., Hosokawa, M., Ogasawara, Y., Tsukada, E., Chiba, K., cDNA cloning, characterization and stable expression of novel human brain carboxylesterase. FEBS Lett 458 (1999), 17–22.
63. Baillie, A.G., Coburn, C.T., Abumrad, N.A., Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J Membr Biol 153 (1996), 75–81.
64. Calvo, D., Gomez-Coronado, D., Suarez, Y., Lasuncion, M.A., Vega, M.A., Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 39 (1998), 777–788.
65. Nicholson, A.C., Frieda, S., Pearce, A., Silverstein, R.L., Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 15 (1995), 269–275.
66. Podrez, E.A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., et al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 277 (2002), 38503–38516.
67. Hajri, T., Han, X.X., Bonen, A., Abumrad, N.A., Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest 109 (2002), 1381–1389.
68. Pols, T.W., Ottenhoff, R., Vos, M., Levels, J.H., Quax, P.H., Meijers, J.C., et al. Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Biochem Biophys Res Commun 366 (2008), 910–916.
69. Bonito, C.A., Nunes, J., Leandro, J., Louro, F., Leandro, P., Ventura, F.V., et al. Unveiling the pathogenic molecular mechanisms of the most common variant (p.K329E) in medium-chain acyl-CoA dehydrogenase deficiency by in vitro and in silico approaches. Biochemistry 55 (2016), 7086–7098.
70. Rakhshandehroo, M., Knoch, B., Muller, M., Kersten, S., Peroxisome proliferator-activated receptor alpha target genes. PPAR Res, 2010, 2010.
71. Duval, C., Muller, M., Kersten, S., PPARalpha and dyslipidemia. Biochim Biophys Acta 1771 (2007), 961–971.
72. Ljungberg, A., Linden, D., Ameen, C., Bergstrom, G., Oscarsson, J., Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism. Growth Horm IGF Res 17 (2007), 154–164.
73. Sun, F., Xie, M.L., Xue, J., Wang, H.B., Osthol regulates hepatic PPAR alpha-mediated lipogenic gene expression in alcoholic fatty liver murine. Phytomedicine 17 (2010), 669–673.
74. Schweiger, M., Schreiber, R., Haemmerle, G., Lass, A., Fledelius, C., Jacobsen, P., et al. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 281 (2006), 40236–40241.